dRx Capital is an institutional investor founded in 2015 and headquartered in San Francisco, United States. Rx Capital is an early-stage venture capital firm that makes invests in the US. The firm focuses on Tech companies including sectors such as Mobile Technology and IT. Also, it invests in Life Sciences start-ups engaged in sectors like Pharmaceutical. Top investments include Cala Health, Science 37, Omada Health. The firm is a joint investment company launched by Novartis and Qualcomm. Notable portfolio companies: Cala Health, Science 37, Omada Health.

Stage

Series A, Series B, growth, early-stage, Series A, Series B, growth, early-stage

Check size

$4M-$30M

HQ

Basel, Switzerland

Founded

2015

Website

http://drxcapital.com

LinkedIn

https://linkedin.com/company/drxcapital

Twitter

http://twitter.com/drxcapital

What they look for

digital health/pharma IT focus; Series A+; primarily US, Switzerland, UK; exceptional teams leveraging data/digital tech for healthcare transformation; backed by Novartis/Qualcomm networks

Preparing to pitch dRx Capital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.